The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the ...

The Centers for Medicare and Medicaid Services has announced the selection of 15 prescription drugs for the third cycle of ...

Medicare selects Botox and Trulicity among 15 high-cost drugs for price negotiations under new federal authority, with lower prices expected in 2028.

The Trump administration on Tuesday announced the 15 drugs selected to participate in the newest round of the Medicare Drug ...

List includes medications for diabetes, cancer, arthritis, and more ...

The Trump administration released the next 15 drugs subject to Medicare price negotiation, including for the first time ...

Lower prices from the third round of talks among Medicare and manufacturers will be announced in the fall but won’t go into ...

CMS's third drug negotiation cycle under the IRA targets high-expenditure drugs, impacting Medicare Part B and D spending. The list includes drugs for cancer, HIV, and diabetes, with significant ...

All 16 drug companies that inked deals with the Trump administration over the past few months still raised some of their ...

Every January, pharmaceutical companies increase the prices of hundreds of drugs. This year there's a disconnect between the ...